NovoCare Pharmacy is Novo Nordisk's direct-to-patient channel for its own GLP-1 medicines — Wegovy and Ozempic, as pens and as tablets. A prescription goes to it, it validates the prescription, and a licensed pharmacy dispenses and ships, or the patient picks up. It does not prescribe, it is not insurance, and it does not sell compounded semaglutide. This page sets out who is behind the name, what it charges and what its terms say, from Novo's own pages and the federal pharmacy register, all read on 2 October 2026.
Lilly runs the equivalent for Zepbound and Foundayo — see how Lilly's own pharmacy service is set up. Prices for every route to Wegovy are on Wegovy cost and for Ozempic on Ozempic cost.
Who is behind the name
"NovoCare" is a brand. The terms on novocare.com name the legal businesses that carry it:
| Name in the terms | What it does, per the terms | Federal NPI register |
|---|---|---|
| Lifefill I, LLC d/b/a Novocare® | "A BlinkRx-affiliated pharmacy licensed in the State of Idaho that serves as the initial prescribe-to pharmacy" | NPI 1225959968 · Boise, Idaho · enumerated 2026-07-21 · active · d/b/a NOVOCARE |
| CoAssist Pharmacy d/b/a Novocare® Legacy | Takes in prescriptions after a benefits check; may dispense, or transfer to CenterWell | NPI 1710671854 · Orlando, Florida · enumerated 2023-06-02 · active · d/b/a NOVOCARE LEGACY |
| BlinkRx | Intake, outreach, accounts, payment, tracking and support; may move a prescription to a network pharmacy | — |
| BlinkRx Network Pharmacies | Dispense and ship; "collectively … licensed to dispense into all 50 states, the District of Columbia, and Puerto Rico" — including pharmacies "unaffiliated with BlinkRx" | — |
| CenterWell® Pharmacy | NovoCare Legacy's dispensing pharmacy: accounts, payment, fulfilment, shipping | — |
| AssistRx | Runs NovoCare Legacy's live support and reimbursement programme | — |
NPI rows from the CMS National Plan and Provider Enumeration System, queried 2 October 2026. CoAssist holds three further NPIs at the same Orlando address.
So there are two front doors with the same name. The current one, Lifefill I in Idaho, was registered in July 2026 and is run with BlinkRx. The older one, CoAssist — now labelled "Legacy" — works with AssistRx and CenterWell. A NovoCare order may be filled by a pharmacy the patient has never heard of; the terms say so plainly.
What it fills, and what it charges
NovoCare's terms list five products: the Wegovy pen, Wegovy HD 7.2 mg, the Wegovy pill, the Ozempic pen and Ozempic tablets. Self-pay prices, read on 2 October 2026:
| Product | Strength | Price per "month" | What a month is |
|---|---|---|---|
| Wegovy pen | 0.25 · 0.5 · 1 · 1.7 · 2.4 mg | $349 | 4 pens, 28 days |
| Wegovy HD pen | 7.2 mg | $399 | 4 pens, 28 days |
| Wegovy pill | 1.5 mg / 4 mg / 9 mg / 25 mg | $149 / $199 / $299 / $299 | 30 tablets, 30 days |
| Ozempic pen | 0.25 or 0.5 mg · 1 mg | $349 | 1 pen, 28 days |
| Ozempic pen | 2 mg | $499 | 1 pen, 28 days |
| Ozempic tablets | 1.5 mg / 4 mg / 9 mg | $149 / $199 / $299 | 30 tablets, 30 days |
The new-patient offer. A patient who has never filled that injection through NovoCare pays $199 for each of the first two 28-day fills of the Wegovy 0.25 or 0.5 mg pen, or the Ozempic 0.25/0.5 mg pen. The prescription must be written and received by 31 December 2026 and shipped by 31 January 2027. The third fill reverts to $349. A similar $149 offer on the 4 mg Wegovy pill required a prescription by 31 August 2026 and is closed.
2- and 3-month fills are priced at exactly two and three times the monthly price — there is no volume discount in the terms.
A year, in dollars
Because a pen "month" is 28 days and a tablet "month" is 30, monthly prices understate what a year costs:
| Route through NovoCare | Fills in a year | Cost for the year |
|---|---|---|
| Wegovy pen, standard $349 | 13 | $4,537 |
| Wegovy pen, new patient (two fills at $199) | 13 | $4,237 |
| Wegovy HD 7.2 mg, $399 | 13 | $5,187 |
| Wegovy pill 25 mg, $299 | ≈ 12.2 | ≈ $3,638 |
| Ozempic pen 2 mg, $499 | 13 | $6,487 |
glp1ledger arithmetic from the published prices: 13 fills of 28 days = 364 days; 365 ÷ 30 = 12.17 bottles. In practice a new patient spends the first months on lower strengths.
Who may use it — and the rules people miss
From the eligibility section of the terms:
- Insured people may self-pay. The programme is for patients who are "either … uninsured or have insurance (either commercial or government-funded), but decide to self-pay". That is the opposite of the manufacturer savings cards, which exclude government beneficiaries.
- But the money does not count. Medicare and other government-plan members attest they "will not attempt to count the cost of this medicine toward your insurance deductible or out-of-pocket limit" and will not seek reimbursement. NovoCare's own page warns every self-payer of the same thing.
- A labelled use only. Patients may participate "only … if they have been prescribed Wegovy® or Ozempic® for an FDA-approved indication within that product's labeling". Ozempic's labelled uses are in type 2 diabetes; Wegovy is the weight-management brand.
- No stacking. The offer "cannot be combined with any other coupon, free trial, discount, prescription savings card, or other offer".
- Supply comes first for those already enrolled. Under "Assurance of Medication Supply", Novo "reserves the right to pause or terminate enrollment to prioritize supply" for enrolled patients who stay "adherent to the treatment".
- A valid prescriber ID is required on the prescription, and NovoCare reviews and validates every prescription before filling.
The insured route at the same site
NovoCare's pharmacy page also advertises, for people with commercial insurance, a Wegovy or Ozempic savings offer of "as little as $25" a month "for up to 3 months", "subject to a maximum savings of $100/month", with government beneficiaries excluded. That is a manufacturer copay offer applied to an insurance claim, governed by the Wegovy and Ozempic savings terms — a different arrangement from the cash programme above, where insurance is not accepted. Coverage questions are on GLP-1 insurance coverage and what plans ask for first on GLP-1 prior authorization.
The drawbacks, stated plainly
- It is still expensive. At standard prices a year of the Wegovy pen is over $4,500, and none of it counts towards an insurance deductible.
- The low price is a starter price. $199 lasts two fills, at the two lowest strengths.
- The dispensing pharmacy can change. The terms allow transfers to network pharmacies, including ones unaffiliated with BlinkRx.
- Enrolment can be paused to protect supply for existing patients.
- One maker only. It sells no Lilly product, no generic and no compounded drug. Comparing makers is covered on Zepbound vs Wegovy and the cheapest routes across all of them on cheapest GLP-1 without insurance.
What it is not
NovoCare is not a prescriber — its page links to telehealth options for people without a prescription — and not a compounding pharmacy; Novo's page carries its own warning about compounded semaglutide, and the difference is explained on compounded semaglutide. For eligible Medicare Part D patients with a weight-management prescription, the federal $50 route is a separate programme: how the Medicare GLP-1 Bridge works.
This page reports what Novo Nordisk's pages and the federal register state. It is not advice on which pharmacy or which medicine to use; treatment decisions belong with the prescriber.
Sources
- Novo Nordisk, "NovoCare® Pharmacy Terms and Conditions of Use" — covered products and NDCs, eligibility and restrictions, the Ozempic and Wegovy injection and tablet self-pay tables, limited-time offer requirements, patient attestation, assurance of supply and third-party partnerships, novocare.com/eligibility/pharmacy.html (via NovoCarePharmacyTerms.com), read 2 October 2026.
- Novo Nordisk, "Get Your GLP-1 Medications Delivered with NovoCare® Pharmacy" — price summary, footnotes, the $25 insured offer and delivery/pickup options, novocare.com/pharmacy.html, read 2 October 2026.
- CMS National Plan and Provider Enumeration System, NPI 1225959968 (Lifefill I, LLC) and NPI 1710671854 (CoAssist Pharmacy, LLC), including the "doing business as" names, npiregistry.cms.hhs.gov, queried 2 October 2026.